2-219013929-T-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_194302.4(CFAP65):āc.3718A>Gā(p.Ile1240Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000547 in 1,461,700 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. I1240F) has been classified as Likely benign.
Frequency
Consequence
NM_194302.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CFAP65 | NM_194302.4 | c.3718A>G | p.Ile1240Val | missense_variant | 22/35 | ENST00000341552.10 | NP_919278.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CFAP65 | ENST00000341552.10 | c.3718A>G | p.Ile1240Val | missense_variant | 22/35 | 5 | NM_194302.4 | ENSP00000340776.5 | ||
CFAP65 | ENST00000453220.5 | c.3718A>G | p.Ile1240Val | missense_variant | 20/33 | 5 | ENSP00000409117.1 | |||
ENSG00000224090 | ENST00000441450.1 | n.200T>C | non_coding_transcript_exon_variant | 3/3 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.00000798 AC: 2AN: 250590Hom.: 0 AF XY: 0.0000147 AC XY: 2AN XY: 135622
GnomAD4 exome AF: 0.00000547 AC: 8AN: 1461700Hom.: 0 Cov.: 32 AF XY: 0.00000688 AC XY: 5AN XY: 727122
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2021 | The c.3718A>G (p.I1240V) alteration is located in exon 22 (coding exon 20) of the CFAP65 gene. This alteration results from a A to G substitution at nucleotide position 3718, causing the isoleucine (I) at amino acid position 1240 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at